ANI Pharmaceuticals | ANIP - EPS Earnings Per Share


ANI Pharmaceuticals reported $2.05 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 2.50 2.04 Nov/11
FY2026Q2 Jun/2026 2.03 1.80 Aug/12
FY2026Q1 Mar/2026 2.05 1.58 1.70 May/08
FY2025Q4 Dec/2025 2.33 1.97 1.63 Feb/27
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Heron Therapeutics USD -0.02 0.02 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.45 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Perrigo USD 0.43 0.34 Mar/2026
Sun Pharmaceuticals INR 9.5 3.3 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026